Unprecedented ‘Meta’ Domain Name Registrations
Client Alert | 1 min read | 11.02.21
Thursday’s announcement that Facebook is rebranding itself as ‘Meta’ resulted in an unprecedented number of new domain name registrations. Since Friday, we have identified over 48,000 new ‘meta’ domain names by way of the award-winning and bespoke brand protection and cybersecurity platform designed and engineered by Crowell & Moring senior counsel Alexander Urbelis.
Critically, a significant number of these newly-registered domains incorporate the names of companies and organizations, or well-known trademarks, e.g., meta-[company name].com or meta[trademark].com. Potentially used for phishing or misinformation, these domains may present cybersecurity issues, and may also constitute threats to brand strength. As a result, we recommend that companies preemptively register domains with the above syntax to prevent them from falling into the hands of cybersquatters or threat actors.
This unprecedented onslaught of domain name registrations also highlights the crossover and complementary nature of brand protection and cybersecurity efforts, giving companies the opportunity to strengthen their cybersecurity posture by protecting valuable trademark rights and prioritizing unauthorized domain registrations en masse.
Contacts
Insights
Client Alert | 3 min read | 04.22.26
Counterfeiting Litigation Targets Online Marketplaces
The landscape of counterfeiting litigation is shifting in ways that place online marketplace operators at the center of disputes from two directions. Brand owners are escalating efforts to hold platforms liable for counterfeit goods sold through their sites, while some marketplace operators have begun joining brand owners as co-plaintiffs to pursue counterfeiters directly. This dual role has significant implications for how platforms manage their legal exposure and their relationships with brand owners.
Client Alert | 10 min read | 04.22.26
The EU Industrial Accelerator Act Proposal’s Significance for the Automotive Industry
Client Alert | 3 min read | 04.21.26
Client Alert | 7 min read | 04.20.26
EU Pharma Package: The “Bolar” Exemption Compromise Proposal

